Denali Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
Good day, everyone, and thank you for joining us at the Virtual UBS Healthcare Conference on our fireside chat with the Denali management team.
I am Esther Rajavelu covering SMID cap biotech here at UBS, and joining me today are Ryan Watts, CEO; and Carole Ho, Chief Medical Officer of Denali. Thank you both for your time. We are excited to have you join us.
Esther, thank you so much. Really great to be here. Looking forward to discussing Denali and really appreciate your interest in our approach to defeating degeneration.
Great. So Ryan perhaps you can start us off with a brief overview of what you're most excited about as you look at the next, I don't know, 6 to 12 to 18 months for Denali.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
